• $765,493.00
    Market Cap
  • -84.88%
    1-Year Change
  • Biotechnology
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 48
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.11
$0.28
$0.11
1-Year Range
$0.05
$1.05
$0.11
Latest Close$0.11
Change
+$0.04 (+42.29%)
Volume637
Market Cap$765,493.00
Shares Outstanding7.2M
Enterprise Value$2.5M

Information as of 10/01/2026

Company Profile

Mosaic ImmunoEngineering Inc.
https://www.mosaicie.com
$765,493.00
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Biotechnology
9114 Adams Avenue, Huntington Beach, CA, United States, 92646
657 208 0890

Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer. The company engages in pursuing new product candidates and platforms to build a pipeline based on immunotherapies. Mosaic ImmunoEngineering, Inc. was founded in 2020 and is based in Huntington Beach, California.

Key Executives

  • Steven W. King
  • Paul J. Lytle
  • Cyril Empig
  • Marvin R. Garovoy
  • Joseph S. Shan

Current Ownership Distribution

  • Insiders6.7M (92.45%)
  • Other547,064 (7.55%)
  • Institutions3 (0.00004%)
  • Mutual Funds0 (0.00%)